Author: Steve Kopczak

• Determination of BRCAness Phenotype in Breast Tumors for the Appointment of Neoadjuvant Chemotherapy Based on Platinum and Taxanes.
• Mihajlovich Tsyganov MM, Ibragimova MK, Garbukov EY, Bragina OD, Karchevskaya AA, Usynin EA, Litvyakov NV.
• Int J Mol Sci. 2022 Dec 22;24(1):207. doi: 10.3390/ijms24010207.

• Free Full Text

• Clinical Cancer and Direct-to-Consumer Genetic Test Result-Sharing Behavior: Findings from HINTS 2020.
• Makhnoon S, Yu R, Peterson SK, Shete S.
• J Pers Med. 2022 Dec 22;13(1):18. doi: 10.3390/jpm13010018.

• Free Full Text

• Cancer prevention in cancer predisposition syndromes: A protocol for testing the feasibility of building a hereditary cancer research registry and nurse navigator follow up model.
• Etchegary H, Pike A, Puddester R, Watkins K, Warren M, Francis V, Woods M, Green J, Savas S, Seal M, Gao Z, Avery S, Curtis F, McGrath J, MacDonald D, Burry TN, Dawson L.
• PLoS One. 2022 Dec 22;17(12):e0279317. doi: 10.1371/journal.pone.0279317.

• PMID: 36548287
• PubMed abstract

• Free Full Text

• Testing for homologous recombination repair or homologous recombination deficiency for poly (ADP-ribose) polymerase inhibitors: A current perspective.
• Herzog TJ, Vergote I, Gomella LG, Milenkova T, French T, Tonikian R, Poehlein C, Hussain M.
• Eur J Cancer. 2023 Jan 1;179:136-146. doi: 10.1016/j.ejca.2022.10.021. Epub ahead of print.

• Review
• Free Full Text

• Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study.
• Taji T, Odan N, Kataoka Y, Ikeda M, Yamaguchi A, Suzuki E, Suwa H.
• Breast Cancer. 2022 Dec 22. doi: 10.1007/s12282-022-01424-3. Epub ahead of print.

• PMID: 36547869
• PubMed abstract
• Source abstract

• Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test?
• Metcalfe KA, Narod SA, Eisen A, Poll A, Zamani N, McCready D, Cil TD, Wright FC, Lerner-Ellis J, McCuaig J, Graham T, Sun P, Akbari MR.
• Cancer Med. 2022 Dec 21. doi: 10.1002/cam4.5515. Epub ahead of print.

• PMID: 36544278
• PubMed abstract

• Free Full Text

• Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can!
• Magliacane G, Brunetto E, Calzavara S, Bergamini A, Pipitone GB, Marra G, Redegallin M, Grassini G, Rabaiotti E, Taccagni G, Pecciarini L, Carrera P, Mangili G, Doglioni C, Cangi MG.
• Cancers (Basel). 2022 Dec 21;15(1):43. doi: 10.3390/cancers15010043.

• Free Full Text

• Fertility Preferences and Practices Among Young Women With Breast Cancer: Germline Genetic Carriers Versus Non-carriers.
• Lewinsohn R, Zheng Y, Rosenberg SM, Ruddy KJ, Tamimi RM, Schapira L, Peppercorn J, Borges VF, Come S, Snow C, Ginsburg ES, Partridge AH.
• Clin Breast Cancer. 2022 Dec 21:S1526-8209(22)00290-7. doi: 10.1016/j.clbc.2022.12.012. Epub ahead of print.

• Source abstract

Related:

•• Identifier: NCT01468246: The Young Women's Breast Cancer Study (HOHO). (ClinicalTrials.gov . Accessed 2022 Dec 21.)

• European Commission Approves Olaparib Plus Abiraterone and Prednisone/Prednisolone for mCRPC.
• Ryan C.
• OncLive. 2022 Dec 21.

• News
• Free Full Text

• A systematic method for detecting abnormal mRNA splicing and assessing its clinical impact in individuals undergoing genetic testing for hereditary cancer syndromes.
• Kamps-Hughes N, Carlton VEH, Fresard L, Osazuwa S, Starks E, Vincent JJ, Albritton S, Nussbaum RL, Nykamp K.
• J Mol Diagn. 2022 Dec 20:S1525-1578(22)00348-8. doi: 10.1016/j.jmoldx.2022.12.002. Epub ahead of print.

• Free Full Text

• Pregnancy-Associated Breast Cancer in BRCA1/2 Carriers: Is Intensified Breast Ultrasound Surveillance Warranted?
• Fruchtman-Brot H, Mango VL.
• Acad Radiol. 2022 Dec 19:S1076-6332(22)00595-5. doi: 10.1016/j.acra.2022.11.004. Epub ahead of print.

• PMID: 36543686
• PubMed abstract
• Source abstract

• Commentary

• Towards Personalized Management of Ovarian Cancer.
• Algethami M, Kulkarni S, Sadiq MT, Tang HKC, Brownlie J, Jeyapalan JN, Mongan NP, Rakha EA, Madhusudan S.
• Cancer Manag Res. 2022 Dec 15;14:3469-3483. doi: 10.2147/CMAR.S366681.

• PMID: 36545222
• PubMed abstract

• Review
• Free PMC article
• Free Full Text

• Testing for homologous recombination repair or homologous recombination deficiency for poly (ADP-ribose) polymerase inhibitors: A current perspective.
• Herzog TJ, Vergote I, Gomella LG, Milenkova T, French T, Tonikian R, Poehlein C, Hussain M.
• Eur J Cancer. 2023 Jan 1;179:136-146. doi: 10.1016/j.ejca.2022.10.021. Epub ahead of print.

• Review
• Free Full Text

• Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test?
• Metcalfe KA, Narod SA, Eisen A, Poll A, Zamani N, McCready D, Cil TD, Wright FC, Lerner-Ellis J, McCuaig J, Graham T, Sun P, Akbari MR.
• Cancer Med. 2022 Dec 21. doi: 10.1002/cam4.5515. Epub ahead of print.

• PMID: 36544278
• PubMed abstract

• Free Full Text

• Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can!
• Magliacane G, Brunetto E, Calzavara S, Bergamini A, Pipitone GB, Marra G, Redegallin M, Grassini G, Rabaiotti E, Taccagni G, Pecciarini L, Carrera P, Mangili G, Doglioni C, Cangi MG.
• Cancers (Basel). 2022 Dec 21;15(1):43. doi: 10.3390/cancers15010043.

• Free Full Text

• Fertility Preferences and Practices Among Young Women With Breast Cancer: Germline Genetic Carriers Versus Non-carriers.
• Lewinsohn R, Zheng Y, Rosenberg SM, Ruddy KJ, Tamimi RM, Schapira L, Peppercorn J, Borges VF, Come S, Snow C, Ginsburg ES, Partridge AH.
• Clin Breast Cancer. 2022 Dec 21:S1526-8209(22)00290-7. doi: 10.1016/j.clbc.2022.12.012. Epub ahead of print.

• Source abstract

Related:

•• Identifier: NCT01468246: The Young Women's Breast Cancer Study (HOHO). (ClinicalTrials.gov . Accessed 2022 Dec 21.)

• European Commission Approves Olaparib Plus Abiraterone and Prednisone/Prednisolone for mCRPC.
• Ryan C.
• OncLive. 2022 Dec 21.

• News
• Free Full Text

• A systematic method for detecting abnormal mRNA splicing and assessing its clinical impact in individuals undergoing genetic testing for hereditary cancer syndromes.
• Kamps-Hughes N, Carlton VEH, Fresard L, Osazuwa S, Starks E, Vincent JJ, Albritton S, Nussbaum RL, Nykamp K.
• J Mol Diagn. 2022 Dec 20:S1525-1578(22)00348-8. doi: 10.1016/j.jmoldx.2022.12.002. Epub ahead of print.

• Free Full Text

• Pregnancy-Associated Breast Cancer in BRCA1/2 Carriers: Is Intensified Breast Ultrasound Surveillance Warranted?
• Fruchtman-Brot H, Mango VL.
• Acad Radiol. 2022 Dec 19:S1076-6332(22)00595-5. doi: 10.1016/j.acra.2022.11.004. Epub ahead of print.

• PMID: 36543686
• PubMed abstract
• Source abstract

• Commentary